Kenji Kasai Selected Research

Kenji Kasai Research Topics

Disease

13	Neoplasms (Cancer) 03/2022 - 12/2013
6	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 10/2019
4	Neoplasm Metastasis (Metastasis) 03/2020 - 12/2008
4	Adenocarcinoma 03/2020 - 10/2008
3	Breast Neoplasms (Breast Cancer) 01/2022 - 10/2015
2	Peritoneal Fibrosis 11/2014 - 01/2010
1	Rhabdomyosarcoma 06/2021
1	Sarcoma (Soft Tissue Sarcoma) 06/2021
1	Ovarian Neoplasms (Ovarian Cancer) 03/2020
1	Colonic Neoplasms (Colon Cancer) 03/2020
1	Malignant Mesothelioma 03/2020
1	Anaphylaxis (Anaphylactic Shock) 01/2020
1	Dyspnea (Shortness of Breath) 01/2020
1	Hypotension (Low Blood Pressure) 01/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020
1	Necrosis 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2020
1	Respiratory Sounds (Crackle) 01/2020
1	Vasculitis (Vasculitides) 01/2020
1	Thrombophilia 07/2019
1	Neutropenia 03/2019
1	Melanoma (Melanoma, Malignant) 03/2019
1	Anemia 03/2019
1	Psoas Abscess 12/2017
1	Pneumothorax 12/2017
1	Abscess 12/2017
1	Carcinogenesis 02/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2015
1	Hyperplasia 01/2015
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2015
1	IGA Glomerulonephritis (IGA Nephropathy) 08/2014
1	Proteinuria 08/2014
1	Hematuria 08/2014
1	Hypoalbuminemia 08/2013
1	Inflammation (Inflammations) 08/2013
1	Amyloidosis 04/2013
1	Neuroendocrine Carcinoma 09/2012
1	Water Intoxication 09/2009
1	Stomach Neoplasms (Stomach Cancer) 12/2008
1	Leukopenia 01/2006
1	Neuroblastoma 01/2004
1	Goiter 11/2003

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2006
4	Calcibiotic Root Canal SealerIBA 03/2022 - 10/2019
4	Transcription Factors (Transcription Factor)IBA 12/2016 - 12/2013
2	Histones (Histone)IBA 05/2021 - 01/2021
2	Immune Checkpoint InhibitorsIBA 03/2021 - 03/2019
2	Dialysis SolutionsIBA 08/2013 - 01/2010
1	Biomarkers (Surrogate Marker)IBA 03/2022
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 03/2022
1	Ligases (Synthetase)IBA 01/2022
1	UbiquitinIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 08/2021
1	RNA (Ribonucleic Acid)IBA 06/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2020
1	MesothelinIBA 03/2020
1	Monoclonal AntibodiesIBA 03/2020
1	Biological ProductsIBA 03/2020
1	Rho Guanine Nucleotide Exchange FactorsIBA 01/2020
1	Contrast MediaIBA 01/2020
1	GadoliniumIBA 01/2020
1	IodineIBA 01/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2020
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2020
1	p21-Activated KinasesIBA 01/2020
1	AnticoagulantsIBA 07/2019
1	NivolumabIBA 03/2019
1	Vancomycin FDA LinkGeneric 12/2017
1	LigandsIBA 12/2016
1	Homeodomain Proteins (Proteins, Homeobox)IBA 02/2016
1	GANT 61IBA 10/2015
1	plastinIBA 10/2015
1	Microfilament Proteins (Actin Binding Proteins)IBA 10/2015
1	Chemokine ReceptorsIBA 10/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Proglucagon (Glucagon Precursors)IBA 01/2015
1	SynaptophysinIBA 01/2015
1	Glucagon (Glukagon)FDA Link 01/2015
1	Chromogranin AIBA 01/2015
1	SteroidsIBA 08/2014
1	CreatinineIBA 08/2014
1	Interleukin-6 (Interleukin 6)IBA 08/2013
1	GelsolinIBA 04/2013
1	SodiumIBA 09/2009
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2008
1	Cisplatin (Platino)FDA LinkGeneric 12/2008
1	Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)IBA 01/2004
1	Monomeric GTP-Binding ProteinsIBA 01/2004
1	Thyroxine (Levothyroxine)FDA LinkGeneric 11/2003

Therapy/Procedure

9	Therapeutics 08/2021 - 01/2002
3	Peritoneal Dialysis 11/2014 - 09/2009
2	Renal Dialysis (Hemodialysis) 12/2017 - 01/2002
2	Aftercare (After-Treatment) 12/2017 - 11/2003
2	Drug Therapy (Chemotherapy) 09/2012 - 12/2008
1	Immunotherapy 10/2019
1	Tonsillectomy 08/2014
1	Adjuvant Chemotherapy 09/2012
1	Splenectomy 12/2008
1	Gastrectomy 12/2008